Previous research indicates that APE1 is abnormally overexpressed in solid tumors, such as gastric cancer and osteosarcoma, and its elevated expression is strongly associated with tumor invasion, metastasis, treatment resistance, and adverse prognosis (11, 12). This evidence concerns the gene APEX1 and neoplasm.